We are live on ! Find out more
MOR

MorphoSys AG American Depositary Shares

Delisted

MOR was delisted on the 2nd of August, 2024.

41 hedge funds and large institutions have $322M invested in MorphoSys AG American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

27% more capital invested

Capital invested by funds: $254M → $322M (+$67.9M)

21% more funds holding

Funds holding: 3441 (+7)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

Holders
41
Holders Change
+7
Holders Change %
+20.59%
% of All Funds
0.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
10
Reduced
12
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$167M -$11.3M -378,633 -7%
TCM
2
TimesSquare Capital Management
New York
$45.3M -$41K -1,371 -0.1%
Franklin Resources
3
Franklin Resources
California
$23.9M
Massachusetts Financial Services
4
Massachusetts Financial Services
Massachusetts
$16.8M +$4.3K +144 +0%
BlackRock
5
BlackRock
New York
$15.9M -$1.89M -63,228 -12%
Bank of America
6
Bank of America
North Carolina
$12.9M -$234K -7,821 -2%
Morgan Stanley
7
Morgan Stanley
New York
$12.8M +$9.26M +309,876 +634%
AA
8
ALPS Advisors
Colorado
$9.14M +$76.7K +2,566 +1%
CS
9
Candriam SCA
Luxembourg
$3.84M +$3.21M +107,621 New
CRC
10
Curi RMB Capital
Illinois
$2.16M +$154K +5,154 +9%
SEI Investments
11
SEI Investments
Pennsylvania
$1.9M +$14.4K +482 +0.9%
VIA
12
Vident Investment Advisory
Georgia
$1.55M -$397K -13,305 -23%
HJIM
13
Henry James International Management
New York
$1.21M +$458K +15,344 +83%
Renaissance Technologies
14
Renaissance Technologies
New York
$826K -$160K -5,354 -19%
Citadel Advisors
15
Citadel Advisors
Florida
$824K +$160K +5,362 +30%
CCM
16
Consonance Capital Management
New York
$769K +$644K +21,561 New
TCM
17
Tekla Capital Management
Massachusetts
$692K +$579K +19,390 New
Envestnet Asset Management
18
Envestnet Asset Management
Illinois
$636K +$51.8K +1,734 +11%
Millennium Management
19
Millennium Management
New York
$553K -$1.55M -51,860 -77%
PPA
20
Parametric Portfolio Associates
Washington
$526K -$28.9K -966 -6%
IBT
21
International Biotechnology Trust
United Kingdom
$402K +$337K +11,295 New
Goldman Sachs
22
Goldman Sachs
New York
$292K -$1.7M -56,822 -87%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$251K +$211K +7,049 New
AI
24
Atria Investments
North Carolina
$226K +$189K +6,334 New
ACM
25
Aquilo Capital Management
California
$217K +$182K +6,080 New

MOR Hedge Fund Activity: Q4 2019 in Review

41 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q4 2019, worth a combined $322M — up 27% from $254M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new MOR positions and 5 closed out — a net gain of 8 holders — while 10 added to existing stakes and 12 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $9.26M. The largest seller was Fidelity Investments, cutting an estimated $11.3M.

  • 41 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q4 2019, up from 34 in Q3 2019.
  • Funds reported $322M of MorphoSys AG American Depositary Shares stock for Q4 2019, up 27% quarter-over-quarter.
  • 13 funds opened new MorphoSys AG American Depositary Shares positions in Q4 2019 and 5 closed out, a net change of +8 holders.
  • The largest MorphoSys AG American Depositary Shares buyer in Q4 2019 was Morgan Stanley, an estimated $9.26M added.
  • The largest MorphoSys AG American Depositary Shares seller in Q4 2019 was Fidelity Investments, an estimated $11.3M sold.

Based on aggregated 13F filings for Q4 2019.